Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,681.52
(
-0.51%
)
US TECH 100
24,025.20
(
-0.44%
)
Dow Jones
46,584.14
(
-0.87%
)
Brent Oil
105.33
(
4.64%
)
Bitcoin
71,267.18
(
-3.63%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zebra4o1 post# 34007

Wednesday, 09/13/2006 11:18:31 PM

Wednesday, September 13, 2006 11:18:31 PM

Post# of 257253
ARNA – If they can get phase-3 done for only $125M, I’ll be impressed—that comes to just $20K per patient, which is not a lot for trials of these durations.

p.s. I have a new example of Zebra’s Law: VRX’s Viramune for program for HCV (#msg-13246012). If this program were owned by a Big Pharma, I think it would now be in the trash can.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now